Key result
Diuretic resistance in heart failure is driven by chronic diuretic use, NSAID interference, and reduced bioavailability, and can be managed by increasing doses, adding thiazide-like drugs, or changing to intravenous administration.
Why the study?
Fluid retention is common in HF, but diuretic resistance can lead to failure to achieve congestion relief despite appropriate diuretic dosing.
What are the mechanisms of and strategies to mitigate diuretic resistance in patients with heart failure?
What are the mechanisms of and strategies to mitigate diuretic resistance in patients with heart failure?
This review outlines the mechanisms of diuretic resistance in heart failure and highlights evidence-based strategies to achieve euvolemia, such as sodium restriction and diuretic regimen modification.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for DR mechanisms and strategies in HF; should not yet change practice pending validation.
Fluid retention is common in patients with heart failure (HF) and diuretics are a major source of management and stabilization. Diuretic resistance (DR) is defined as a failure to achieve therapeutically desired congestion relief despite using an appropriate diuretic dose. In this study, the underlying mechanisms of DR in HF patients are described and several currently available evidence-based strategies to mitigate this condition are provided. Specific aims were to investigate how DR occurs in patients with HF, how HF medications interfere with diuretic treatment, and what alternative methods are available for patients with DR while undergoing treatment for HF. Results provide several rationales for novel strategies used to help reach a state of euvolemia where there is a proper amount of blood in the circulatory system. These include reducing sodium intake, changing the timing of drug administration, and modifying diuretic dose.
No takes yet. Share an insight, caveat, or question.
Shams et al. (2022) conducted a review in Heart Failure. Diuretic therapy was evaluated. Diuretic resistance in heart failure is driven by chronic diuretic use, NSAID interference, and reduced bioavailability, and can be managed by increasing doses, adding thiazide-like drugs, or changing to intravenous administration.
Synapse has enriched 10 related papers. Consider them for comparative context: